Acute non-variceal upper gastrointestinal bleeding
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects voluntarily join the study and sign the informed consent; 2. Patients aged 18-80 years; 3. Able to tolerate and agree to endoscopic diagnosis and treatment; 4. Patients who meet the diagnosis of ANVUGIB high-risk patients; 5. Patients who have not received other endoscopic treatment after bleeding.
Exclusion criteria
Exclusion criteria: 1. Patients with impaired consciousness and hemorrhagic shock; 2. Patients who are unable to cooperate with or do not agree to endoscopic diagnosis and treatment; 3. Patients with serious heart, brain, and lung diseases; 4. Patients with esophageal varices or upper gastrointestinal malignant tumors; 5. Patients with abnormal or altered anatomical structures who cannot complete endoscopic diagnosis and treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immediate hemostasis rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| 7-day rebleeding rate;30-day rebleeding rate;Operation time;Blood transfusion volume;Length of hospital stay;Expenses of hospital stay;Incidence of adverse events; | — |
Countries
China
Contacts
Shenzhen Second People’s Hospital, Shenzhen, China